Unlocking the therapeutic potential of E3 ubiquitin ligases through structure-function studies and Cryo-EM
Unlocking the therapeutic potential of E3 ubiquitin ligases through structure-function studies and Cryo-EM
批准号:
2275804
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
All cells within our body need to discard waste material such as damaged or no longer wanted proteinsto ensure that cells remain healthy and functional. The small protein ubiquitin is essential in thisprocess by functioning as an identification tag. Ubiquitin is the most versatile post-translationalmodification, it can exist as a single moiety on proteins, and this is important in protein trafficking andendocytosis, but also as a ubiquitin chain. It is only in the last decade that we have come to appreciatethe complexity of the ubiquitin system. We now know for instance that ubiquitin can use any of itsseven lysine residues, or its N-terminal Met, to assemble two ubiquitin chains together in order toform chains. Therefore, as many as eight linkage types have been found on proteins (i.e. Met1, K6,K11, K27, K29, K33, K48 and K63) in yeast and human cells.E3 ubiquitin ligases plays a key role in protein ubiquitination, by mediating the transfer of ubiquitinonto protein substrates. Depending on the type of ubiquitin signal added, this can trigger recognitionby the Ubiquitin-Proteasome System. Therefore, preventing the degradation of important proteins inage-related diseases could in theory be achieved through the targeted inhibition of the ligase activityof specific E3s, rather than the current and general/unspecific approach of inhibiting the proteasome.E3 HECT ligases are very good candidates for drug discovery given their Cys-based enzyme activity.However, the limited structural information and biochemical knowledge of these large enzymes hashindered their potential as therapeutic targets, despite mounting evidence for their importance inhuman health.In this project, the student will undertake structure-function studies of E3 HECT ubiquitin ligases. Thestudent will be trained in protein expression and purification, ubiquitination assays, biophysicaltechniques, protein crystallography and state-of-the-art Cryo-EM. An important goal will be to alsoestablish strategies for the expression and purification of full-length HECT E3 enzymes in eukaryoticsystems, for Cryo-EM studies and future drug discovery projects. This project will benefit from ongoinginternational collaboration with experts in proteomics and chemical biology as well as supportive anddynamic research environments at Bath and Bristol. Because of our combined expertise in proteinubiquitination, structure-function studies and Cryo-EM, the student will be in an ideal position to makean impact on the ubiquitin field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82371809
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:聂红
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
-
批准号:82372014
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:魏伟军
-
依托单位: